Global Initiative To Demonstrate Operational Excellence in Nigeria for Metastatic Colorectal Cancer Patients
Recently, the Innovative Cancer Medicines (ICM) initiative announced the enrollment of the first Nigerian patient in a pioneering demonstration project to provide an immunotherapy drug used to treat cancer.
Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India
PATH has launched a groundbreaking initiative to address the rising burden of hemoglobinopathies—particularly Thalassemia—in India, with the support of a grant from the Bristol Myers Squibb Foundation (BMS Foundation). The program aims to strengthen local health systems.
HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb
HopeHealth announced that it is participating in a pivotal phase 3 clinical research study, sponsored by global pharmaceutical company Bristol Myers Squibb (BMS), to evaluate an investigational treatment in patients with systemic lupus erythematosus (SLE).
Every Word Matters: The Next Chapter of Our Universal Patient Language
At Bristol Myers Squibb (BMS), we believe that how we communicate can be just as important as what we’re communicating — especially when it comes to people’s health.
Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives
Recently, Bristol Myers Squibb (NYSE: BMY) and the National Community Pharmacists Association (NCPA) announced a new collaboration aimed at improving heart health in rural communities in the United States.
Winn CIPP Welcomes Cohort 4 Medical Students Focused on Connecting Communities to Clinical Research
The Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP), a national program out of VCU Massey Comprehensive Cancer Center, has officially launched its fourth annual cohort, taking place during the summer of 2025.
Markey Researchers Awarded $6.8 Million To Help Others Replicate Kentucky’s Lung Cancer Screening Success
A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) Cancer Center is set to expand its reach, thanks to a $6.8 million grant from the Bristol Myers Squibb Foundation.
Improving Access to Care by Strengthening Local Health System Capacity
We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, bringing new hope to patients across the world. Unfortunately, these breakthroughs fail to reach everyone due to barriers to care.
Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year
Bristol Myers Squibb announced that it has been named in the prestigious Dow Jones Sustainability Index (DJSI) for the second consecutive year. This recognition further validates the company’s impactful progress towards and prioritization of its ESG initiatives and aspirations.
One Community at a Time: Enabling Early Lung Cancer Detection Across the U.S.
Early detection through screening is key to improving lung cancer survivorship – when lung cancer is discovered early enough to be surgically removed before spreading, a patient's chance of surviving five years jumps from 4% to 55%.